Summary
The global Adalimumab Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Adalimumab Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Adalimumab Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- AbbVie
- Amgen
- Sandoz
- Boehringer Ingelheim
- Mylan
- Biogen
- ...
By the Product Type, the market is primarily segmented into:
- Adalimumab
- Adalimumab Biosimilar
By Applications, the market is segmented into:
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Adalimumab Market Report:
- To assess the size of the market by value and volume
- Analyze the Adalimumab Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Adalimumab Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Adalimumab Market
The Adalimumab Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Adalimumab Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
1 Study Coverage
1.1 Adalimumab Product Introduction
1.2 Market Segments
1.3 Key Adalimumab Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Adalimumab Market Size Growth Rate by Type
1.4.2 Adalimumab
1.4.3 Adalimumab Biosimilar
1.5 Market by Application
1.5.1 Global Adalimumab Market Size Growth Rate by Application
1.5.2 Adults
1.5.3 Children
1.6 Coronavirus Disease 2019 (Covid-19): Adalimumab Industry Impact
1.6.1 How the Covid-19 is Affecting the Adalimumab Industry
1.6.1.1 Adalimumab Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Adalimumab Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Adalimumab Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Adalimumab Market Size Estimates and Forecasts
2.1.1 Global Adalimumab Revenue 2015-2026
2.1.2 Global Adalimumab Sales 2015-2026
2.2 Adalimumab Market Size by Region: 2020 Versus 2026
2.2.1 Global Adalimumab Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Adalimumab Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Adalimumab Competitor Landscape by Players
3.1 Adalimumab Sales by Manufacturers
3.1.1 Adalimumab Sales by Manufacturers (2015-2020)
3.1.2 Adalimumab Sales Market Share by Manufacturers (2015-2020)
3.2 Adalimumab Revenue by Manufacturers
3.2.1 Adalimumab Revenue by Manufacturers (2015-2020)
3.2.2 Adalimumab Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Adalimumab Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Adalimumab Revenue in 2019
3.2.5 Global Adalimumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Adalimumab Price by Manufacturers
3.4 Adalimumab Manufacturing Base Distribution, Product Types
3.4.1 Adalimumab Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Adalimumab Product Type
3.4.3 Date of International Manufacturers Enter into Adalimumab Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Adalimumab Market Size by Type (2015-2020)
4.1.1 Global Adalimumab Sales by Type (2015-2020)
4.1.2 Global Adalimumab Revenue by Type (2015-2020)
4.1.3 Adalimumab Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Adalimumab Market Size Forecast by Type (2021-2026)
4.2.1 Global Adalimumab Sales Forecast by Type (2021-2026)
4.2.2 Global Adalimumab Revenue Forecast by Type (2021-2026)
4.2.3 Adalimumab Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Adalimumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Adalimumab Market Size by Application (2015-2020)
5.1.1 Global Adalimumab Sales by Application (2015-2020)
5.1.2 Global Adalimumab Revenue by Application (2015-2020)
5.1.3 Adalimumab Price by Application (2015-2020)
5.2 Adalimumab Market Size Forecast by Application (2021-2026)
5.2.1 Global Adalimumab Sales Forecast by Application (2021-2026)
5.2.2 Global Adalimumab Revenue Forecast by Application (2021-2026)
5.2.3 Global Adalimumab Price Forecast by Application (2021-2026)
6 North America
6.1 North America Adalimumab by Country
6.1.1 North America Adalimumab Sales by Country
6.1.2 North America Adalimumab Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Adalimumab Market Facts & Figures by Type
6.3 North America Adalimumab Market Facts & Figures by Application
7 Europe
7.1 Europe Adalimumab by Country
7.1.1 Europe Adalimumab Sales by Country
7.1.2 Europe Adalimumab Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Adalimumab Market Facts & Figures by Type
7.3 Europe Adalimumab Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Adalimumab by Region
8.1.1 Asia Pacific Adalimumab Sales by Region
8.1.2 Asia Pacific Adalimumab Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Adalimumab Market Facts & Figures by Type
8.3 Asia Pacific Adalimumab Market Facts & Figures by Application
9 Latin America
9.1 Latin America Adalimumab by Country
9.1.1 Latin America Adalimumab Sales by Country
9.1.2 Latin America Adalimumab Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Adalimumab Market Facts & Figures by Type
9.3 Central & South America Adalimumab Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Adalimumab by Country
10.1.1 Middle East and Africa Adalimumab Sales by Country
10.1.2 Middle East and Africa Adalimumab Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Adalimumab Market Facts & Figures by Type
10.3 Middle East and Africa Adalimumab Market Facts & Figures by Application
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description, Business Overview and Total Revenue
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Adalimumab Products Offered
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description, Business Overview and Total Revenue
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Adalimumab Products Offered
11.2.5 Amgen Recent Development
11.3 Sandoz
11.3.1 Sandoz Corporation Information
11.3.2 Sandoz Description, Business Overview and Total Revenue
11.3.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sandoz Adalimumab Products Offered
11.3.5 Sandoz Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.4.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim Adalimumab Products Offered
11.4.5 Boehringer Ingelheim Recent Development
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description, Business Overview and Total Revenue
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Adalimumab Products Offered
11.5.5 Mylan Recent Development
11.6 Biogen
11.6.1 Biogen Corporation Information
11.6.2 Biogen Description, Business Overview and Total Revenue
11.6.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Biogen Adalimumab Products Offered
11.6.5 Biogen Recent Development
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description, Business Overview and Total Revenue
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Adalimumab Products Offered
11.1.5 AbbVie Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Adalimumab Market Estimates and Projections by Region
12.1.1 Global Adalimumab Sales Forecast by Regions 2021-2026
12.1.2 Global Adalimumab Revenue Forecast by Regions 2021-2026
12.2 North America Adalimumab Market Size Forecast (2021-2026)
12.2.1 North America: Adalimumab Sales Forecast (2021-2026)
12.2.2 North America: Adalimumab Revenue Forecast (2021-2026)
12.2.3 North America: Adalimumab Market Size Forecast by Country (2021-2026)
12.3 Europe Adalimumab Market Size Forecast (2021-2026)
12.3.1 Europe: Adalimumab Sales Forecast (2021-2026)
12.3.2 Europe: Adalimumab Revenue Forecast (2021-2026)
12.3.3 Europe: Adalimumab Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Adalimumab Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Adalimumab Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Adalimumab Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Adalimumab Market Size Forecast by Region (2021-2026)
12.5 Latin America Adalimumab Market Size Forecast (2021-2026)
12.5.1 Latin America: Adalimumab Sales Forecast (2021-2026)
12.5.2 Latin America: Adalimumab Revenue Forecast (2021-2026)
12.5.3 Latin America: Adalimumab Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Adalimumab Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Adalimumab Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Adalimumab Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Adalimumab Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porters Five Forces Analysis
13.5 Primary Interviews with Key Adalimumab Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Adalimumab Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Table
List of Tables
Table 1. Adalimumab Market Segments
Table 2. Ranking of Global Top Adalimumab Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Adalimumab Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Adalimumab
Table 5. Major Manufacturers of Adalimumab Biosimilar
Table 6. COVID-19 Impact Global Market: (Four Adalimumab Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Adalimumab Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Adalimumab Players to Combat Covid-19 Impact
Table 11. Global Adalimumab Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Adalimumab Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Adalimumab Sales by Regions 2015-2020 (K Units)
Table 14. Global Adalimumab Sales Market Share by Regions (2015-2020)
Table 15. Global Adalimumab Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Adalimumab Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Adalimumab Sales Share by Manufacturers (2015-2020)
Table 18. Global Adalimumab Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Adalimumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adalimumab as of 2019)
Table 20. Adalimumab Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Adalimumab Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Adalimumab Price (2015-2020) (USD/Unit)
Table 23. Adalimumab Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Adalimumab Product Type
Table 25. Date of International Manufacturers Enter into Adalimumab Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Adalimumab Sales by Type (2015-2020) (K Units)
Table 28. Global Adalimumab Sales Share by Type (2015-2020)
Table 29. Global Adalimumab Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Adalimumab Revenue Share by Type (2015-2020)
Table 31. Adalimumab Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Adalimumab Sales by Application (2015-2020) (K Units)
Table 33. Global Adalimumab Sales Share by Application (2015-2020)
Table 34. North America Adalimumab Sales by Country (2015-2020) (K Units)
Table 35. North America Adalimumab Sales Market Share by Country (2015-2020)
Table 36. North America Adalimumab Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Adalimumab Revenue Market Share by Country (2015-2020)
Table 38. North America Adalimumab Sales by Type (2015-2020) (K Units)
Table 39. North America Adalimumab Sales Market Share by Type (2015-2020)
Table 40. North America Adalimumab Sales by Application (2015-2020) (K Units)
Table 41. North America Adalimumab Sales Market Share by Application (2015-2020)
Table 42. Europe Adalimumab Sales by Country (2015-2020) (K Units)
Table 43. Europe Adalimumab Sales Market Share by Country (2015-2020)
Table 44. Europe Adalimumab Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Adalimumab Revenue Market Share by Country (2015-2020)
Table 46. Europe Adalimumab Sales by Type (2015-2020) (K Units)
Table 47. Europe Adalimumab Sales Market Share by Type (2015-2020)
Table 48. Europe Adalimumab Sales by Application (2015-2020) (K Units)
Table 49. Europe Adalimumab Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Adalimumab Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Adalimumab Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Adalimumab Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Adalimumab Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Adalimumab Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Adalimumab Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Adalimumab Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Adalimumab Sales Market Share by Application (2015-2020)
Table 58. Latin America Adalimumab Sales by Country (2015-2020) (K Units)
Table 59. Latin America Adalimumab Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Adalimumab Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Adalimumab Revenue Market Share by Country (2015-2020)
Table 62. Latin America Adalimumab Sales by Type (2015-2020) (K Units)
Table 63. Latin America Adalimumab Sales Market Share by Type (2015-2020)
Table 64. Latin America Adalimumab Sales by Application (2015-2020) (K Units)
Table 65. Latin America Adalimumab Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Adalimumab Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Adalimumab Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Adalimumab Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Adalimumab Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Adalimumab Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Adalimumab Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Adalimumab Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Adalimumab Sales Market Share by Application (2015-2020)
Table 74. AbbVie Corporation Information
Table 75. AbbVie Description and Major Businesses
Table 76. AbbVie Adalimumab Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. AbbVie Product
Table 78. AbbVie Recent Development
Table 79. Amgen Corporation Information
Table 80. Amgen Description and Major Businesses
Table 81. Amgen Adalimumab Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Amgen Product
Table 83. Amgen Recent Development
Table 84. Sandoz Corporation Information
Table 85. Sandoz Description and Major Businesses
Table 86. Sandoz Adalimumab Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Sandoz Product
Table 88. Sandoz Recent Development
Table 89. Boehringer Ingelheim Corporation Information
Table 90. Boehringer Ingelheim Description and Major Businesses
Table 91. Boehringer Ingelheim Adalimumab Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Boehringer Ingelheim Product
Table 93. Boehringer Ingelheim Recent Development
Table 94. Mylan Corporation Information
Table 95. Mylan Description and Major Businesses
Table 96. Mylan Adalimumab Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Mylan Product
Table 98. Mylan Recent Development
Table 99. Biogen Corporation Information
Table 100. Biogen Description and Major Businesses
Table 101. Biogen Adalimumab Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Biogen Product
Table 103. Biogen Recent Development
Table 104. Global Adalimumab Sales Forecast by Regions (2021-2026) (K Units)
Table 105. Global Adalimumab Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Adalimumab Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Adalimumab Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Adalimumab Sales Forecast by Country (2021-2026) (K Units)
Table 109. North America: Adalimumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Adalimumab Sales Forecast by Country (2021-2026) (K Units)
Table 111. Europe: Adalimumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Adalimumab Sales Forecast by Region (2021-2026) (K Units)
Table 113. Asia Pacific: Adalimumab Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Adalimumab Sales Forecast by Country (2021-2026) (K Units)
Table 115. Latin America: Adalimumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Adalimumab Sales Forecast by Country (2021-2026) (K Units)
Table 117. Middle East and Africa: Adalimumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Adalimumab Players
Table 122. Adalimumab Customers List
Table 123. Adalimumab Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Adalimumab Product Picture
Figure 2. Global Adalimumab Sales Market Share by Type in 2020 & 2026
Figure 3. Adalimumab Product Picture
Figure 4. Adalimumab Biosimilar Product Picture
Figure 5. Global Adalimumab Sales Market Share by Application in 2020 & 2026
Figure 6. Adults
Figure 7. Children
Figure 8. Adalimumab Report Years Considered
Figure 9. Global Adalimumab Market Size 2015-2026 (US$ Million)
Figure 10. Global Adalimumab Sales 2015-2026 (K Units)
Figure 11. Global Adalimumab Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Adalimumab Sales Market Share by Region (2015-2020)
Figure 13. Global Adalimumab Sales Market Share by Region in 2019
Figure 14. Global Adalimumab Revenue Market Share by Region (2015-2020)
Figure 15. Global Adalimumab Revenue Market Share by Region in 2019
Figure 16. Global Adalimumab Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Adalimumab Revenue in 2019
Figure 18. Adalimumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Adalimumab Sales Market Share by Type (2015-2020)
Figure 20. Global Adalimumab Sales Market Share by Type in 2019
Figure 21. Global Adalimumab Revenue Market Share by Type (2015-2020)
Figure 22. Global Adalimumab Revenue Market Share by Type in 2019
Figure 23. Global Adalimumab Market Share by Price Range (2015-2020)
Figure 24. Global Adalimumab Sales Market Share by Application (2015-2020)
Figure 25. Global Adalimumab Sales Market Share by Application in 2019
Figure 26. Global Adalimumab Revenue Market Share by Application (2015-2020)
Figure 27. Global Adalimumab Revenue Market Share by Application in 2019
Figure 28. North America Adalimumab Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Adalimumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Adalimumab Sales Market Share by Country in 2019
Figure 31. North America Adalimumab Revenue Market Share by Country in 2019
Figure 32. U.S. Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Adalimumab Market Share by Type in 2019
Figure 37. North America Adalimumab Market Share by Application in 2019
Figure 38. Europe Adalimumab Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Adalimumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Adalimumab Sales Market Share by Country in 2019
Figure 41. Europe Adalimumab Revenue Market Share by Country in 2019
Figure 42. Germany Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Adalimumab Market Share by Type in 2019
Figure 53. Europe Adalimumab Market Share by Application in 2019
Figure 54. Asia Pacific Adalimumab Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Adalimumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Adalimumab Sales Market Share by Region in 2019
Figure 57. Asia Pacific Adalimumab Revenue Market Share by Region in 2019
Figure 58. China Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Adalimumab Market Share by Type in 2019
Figure 81. Asia Pacific Adalimumab Market Share by Application in 2019
Figure 82. Latin America Adalimumab Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Adalimumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Adalimumab Sales Market Share by Country in 2019
Figure 85. Latin America Adalimumab Revenue Market Share by Country in 2019
Figure 86. Mexico Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Adalimumab Market Share by Type in 2019
Figure 93. Latin America Adalimumab Market Share by Application in 2019
Figure 94. Middle East and Africa Adalimumab Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Adalimumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Adalimumab Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Adalimumab Revenue Market Share by Country in 2019
Figure 98. Turkey Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Adalimumab Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Adalimumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Adalimumab Market Share by Type in 2019
Figure 105. Middle East and Africa Adalimumab Market Share by Application in 2019
Figure 106. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. North America Adalimumab Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America Adalimumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Adalimumab Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe Adalimumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Adalimumab Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific Adalimumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Adalimumab Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America Adalimumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Adalimumab Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa Adalimumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
Request Discount 
Inquire Before Buy
